LeMaitre Vascular Inc (LMAT) stock
LMATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 22/3022% below fair value
$76.10−0.91 (-1.18%)
Close on Nov 17, 2026Market cap $1.74BP/E 26.7Yield 1.05%
LeMaitre Vascular operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
LeMaitre Vascular's operating cash flow for the twelve months ending Jun 30, 2026 was $82.98M, up 41.2% year over year. For fiscal 2025 it was $81.25M, up 84.1% from the year before. Over ten years it grew 21.7% a year on average. The highest annual figure on record is $81.25M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $81.25M | +84.1% |
| FY2024 | Dec 31, 2024 | $44.12M | +20.1% |
| FY2023 | Dec 31, 2023 | $36.75M | +44.8% |
| FY2022 | Dec 31, 2022 | $25.38M | -27.7% |
| FY2021 | Dec 31, 2021 | $35.10M | +0.9% |
| FY2020 | Dec 31, 2020 | $34.80M | +145.4% |
| FY2019 | Dec 31, 2019 | $14.18M | -27.3% |
| FY2018 | Dec 31, 2018 | $19.51M | -14.7% |
| FY2017 | Dec 31, 2017 | $22.87M | +35.3% |
| FY2016 | Dec 31, 2016 | $16.90M | +47.7% |
| FY2015 | Dec 31, 2015 | $11.44M | +107.5% |
| FY2014 | Dec 31, 2014 | $5.51M | +2.3% |
| FY2013 | Dec 31, 2013 | $5.39M | +14.1% |
| FY2012 | Dec 31, 2012 | $4.72M | +49.0% |
| FY2011 | Dec 31, 2011 | $3.17M | -55.0% |
| FY2010 | Dec 31, 2010 | $7.05M | +29.6% |
| FY2009 | Dec 31, 2009 | $5.44M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $15.97M | -21.3% |
| Q1 FY2026 | Mar 31, 2026 | $15.09M | +67.0% |
| Q4 FY2025 | Dec 31, 2025 | $23.16M | +52.5% |
| Q3 FY2025 | Sep 30, 2025 | $28.76M | +101.9% |
| Q2 FY2025 | Jun 30, 2025 | $20.29M | +110.8% |
| Q1 FY2025 | Mar 31, 2025 | $9.04M | +78.2% |
| Q4 FY2024 | Dec 31, 2024 | $15.18M | +41.3% |
| Q3 FY2024 | Sep 30, 2024 | $14.25M | +20.5% |
| Q2 FY2024 | Jun 30, 2024 | $9.63M | -19.1% |
| Q1 FY2024 | Mar 31, 2024 | $5.07M | +122.5% |
| Q4 FY2023 | Dec 31, 2023 | $10.75M | +163.6% |
| Q3 FY2023 | Sep 30, 2023 | $11.82M | +61.0% |
| Q2 FY2023 | Jun 30, 2023 | $11.90M | +28.7% |
| Q1 FY2023 | Mar 31, 2023 | $2.28M | -51.6% |
| Q4 FY2022 | Dec 31, 2022 | $4.08M | -19.4% |
| Q3 FY2022 | Sep 30, 2022 | $7.34M | -47.8% |
| Q2 FY2022 | Jun 30, 2022 | $9.25M | -6.6% |
| Q1 FY2022 | Mar 31, 2022 | $4.71M | -22.4% |
| Q4 FY2021 | Dec 31, 2021 | $5.06M | -64.3% |
| Q3 FY2021 | Sep 30, 2021 | $14.08M | -0.3% |
| Q2 FY2021 | Jun 30, 2021 | $9.90M | +85.1% |
| Q1 FY2021 | Mar 31, 2021 | $6.07M | +410.8% |
| Q4 FY2020 | Dec 31, 2020 | $14.15M | +153.0% |
| Q3 FY2020 | Sep 30, 2020 | $14.11M | +215.7% |
| Q2 FY2020 | Jun 30, 2020 | $5.35M | +23.4% |
| Q1 FY2020 | Mar 31, 2020 | $1.19M | – |
| Q4 FY2019 | Dec 31, 2019 | $5.59M | -14.9% |
| Q3 FY2019 | Sep 30, 2019 | $4.47M | +3.8% |
| Q2 FY2019 | Jun 30, 2019 | $4.33M | -11.1% |
| Q1 FY2019 | Mar 31, 2019 | -$219.00K | -105.8% |
| Q4 FY2018 | Dec 31, 2018 | $6.57M | -2.9% |
| Q3 FY2018 | Sep 30, 2018 | $4.31M | -47.5% |
| Q2 FY2018 | Jun 30, 2018 | $4.88M | -10.1% |
| Q1 FY2018 | Mar 31, 2018 | $3.75M | +51.5% |
| Q4 FY2017 | Dec 31, 2017 | $6.77M | +61.4% |
| Q3 FY2017 | Sep 30, 2017 | $8.20M | +29.1% |
| Q2 FY2017 | Jun 30, 2017 | $5.42M | – |
| Q1 FY2017 | Mar 31, 2017 | $2.48M | – |
| Q4 FY2016 | Dec 31, 2016 | $4.19M | – |
| Q3 FY2016 | Sep 30, 2016 | $6.35M | – |
See a number that looks wrong?